Sintair 4 Mg, 5Mg Chewable Tablets And 10 Mg Tablets 4 mg, 5mg, 10 mg Chewable tablet
PDF Leaflet Revision Date: 17 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma.
Dosage (summary)
4 mg for 2-5 years, 5 mg for 6-14 years, 10 mg for 15 years and older, once daily in the evening.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation; potential congenital defects reported.
Key Drug Interactions
- Phenobarbitone
- Gemfibrozil
- CYP inducers/inhibitors
Contraindications
- Hypersensitivity to montelukast
- Children under 2 years
- Pregnancy
- Lactation
Common side effects
- Headache
- Dizziness
- Upper respiratory infection
- Abnormal dreams
Counselling Points
- Take daily as prescribed
- Continue during asthma control
- Report neuropsychiatric symptoms
Serious warnings
- Not for acute asthma attacks
- Risk of neuropsychiatric events
- Eosinophilia risk
Important Disclaimer
The Sintair 4 Mg, 5Mg Chewable Tablets And 10 Mg Tablets 4 mg, 5mg, 10 mg Chewable tablet professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
